# Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh

> **NCT05475379** · PHASE1,PHASE2 · COMPLETED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 630 (actual)

## Conditions studied

- Typhoid

## Interventions

- **BIOLOGICAL:** Typhoid Vi polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT)

## Key facts

- **NCT ID:** NCT05475379
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-31
- **Target enrollment:** 630 (ACTUAL)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05475379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05475379, "Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05475379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*